Results 31 to 40 of about 29,629,799 (238)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Introduction: RTS,S/AS01 is currently the most advanced malaria vaccine but provides incomplete, short-term protection. It was developed for use within the expanded program on immunizations (EPI) for African children. Another use could be adding mass RTS,
Lorenz von Seidlein   +21 more
doaj   +1 more source

Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals [PDF]

open access: yes, 2009
Background MB2 protein is a sporozoite surface antigen on the human malaria parasite Plasmodium falciparum. MB2 was identified by screening a P. falciparum sporozoite cDNA expression library using immune sera from a protected donor immunized via the ...
James Anthony A   +30 more
core   +1 more source

Plasmodium malariae contributes to high levels of malaria transmission in a forest–savannah transition area in Cameroon

open access: yesParasites & Vectors, 2023
Background Malaria control efforts are highly skewed towards Plasmodium falciparum while overlooking other Plasmodium species such as P. malariae. A better understanding of the role of Plasmodium species other than P.
Daniel Nguiffo-Nguete   +9 more
doaj   +1 more source

Erythrocyte binding peptides: a story in the search for a malaria vaccine [PDF]

open access: yesExploration of Drug Science
Merozoite invasion of erythrocytes relies on molecular interactions between parasite and host proteins, making these proteins potential therapeutic targets.
Mauricio Urquiza-Martinez   +2 more
doaj   +1 more source

The diagnostic and prognostic value of conventional and rapid diagnostic tools in malaria [PDF]

open access: yesAl Ameen Journal of Medical Sciences, 2016
Background: The burden of malaria is raising all over the world and India is no exception. Despite well established treatment regimens and diagnostic tools, Malaria is thought to kill between1.1 to 2.7 million people worldwide each year.
Chandrakanth C.H
doaj  

Plasmodium falciparum Malaria Susceptibility and Severity: Influence of MyD88-Adaptor-Like Gene (rs8177374) Polymorphism

open access: yesInfection and Drug Resistance, 2022
Amany I Ammar,1 Sally M El-Hefnawy,2 Somaia Shehab-Eldeen,3,4 Abdallah Essa,3,4 Sherin S ELnaidany,2 Rasha G Mostafa,5 Mortadah H Alsalman,4 Samar A El-Refai1 1Department of Medical Parasitology, Faculty of Medicine, Menoufia University, Shebin Elkom ...
Ammar AI   +7 more
doaj  

Mechanisms for Host Immune Evasion Mediated by Plasmodium falciparum-Infected Erythrocyte Surface Antigens

open access: yesFrontiers in Immunology, 2022
Plasmodium falciparum infection causes the most severe form of malaria. It has been hypothesized that P. falciparum directly suppresses host immune responses because sufficient acquired immunity is often not induced even by repeated P.
Akihito Sakoguchi   +3 more
doaj   +1 more source

Plasmodium vivax populations are more genetically diverse and less structured than sympatric Plasmodium falciparum populations [PDF]

open access: yes, 2015
The human malaria parasite, Plasmodium vivax, is proving more difficult to control and eliminate than Plasmodium falciparum in areas of co-transmission.
Ingrid Felger (92160)   +55 more
core   +1 more source

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. [PDF]

open access: yes, 2014
Adequate clinical and parasitologic cure by artemisinin combination therapies relies on the artemisinin component and the partner drug. Polymorphisms in the Plasmodium falciparum chloroquine resistance transporter (pfcrt) and P.
Sibley, CH   +144 more
core   +2 more sources

Late dihydroartemisinin-piperaquine treatment failure of P. falciparum malaria attack related to insufficient dosing in an obese patient

open access: yesIDCases, 2023
We report the case of an obese patient who experienced late failure on day28 of a well-conducted treatment with artesunate, followed by dihydroartemisinin-piperaquine (DHA-PPQ) for a severe P. falciparum malaria attack. The same P.
M. Parisey   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy